Search

Your search keyword '"Mehrazin, Reza"' showing total 939 results

Search Constraints

Start Over You searched for: Author "Mehrazin, Reza" Remove constraint Author: "Mehrazin, Reza"
939 results on '"Mehrazin, Reza"'

Search Results

1. The impact of single-port robotic surgery: a survey among urology residents and fellows in the United States

2. Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry

3. Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols

11. Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

12. Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial Carcinoma

15. Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

16. Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy

17. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium

19. Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group

23. Infections After Adoption of Antibiogram-directed Prophylaxis and Intracorporeal Urinary Diversion for Robot-assisted Radical Cystectomy

24. The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry

25. Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)

26. Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment

27. Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma

28. Retroperitoneal Robot-assisted Partial Nephrectomy: A Systematic Review and Pooled Analysis of Comparative Outcomes

30. Minimally Invasive Management of Inguinal Lymph Nodes in Penile Cancer: Recent Progress and Remaining Challenges.

31. A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)

32. MP44-08 PATIENTS WITH IMPERATIVE ROBOT-ASSISTED PARTIAL NEPHRECTOMY HAVE WORSE OUTCOMES THAN THOSE WITH ELECTIVE INDICATIONS

33. PD02-07 POSITIVE CTDNA STATUS BEFORE RADICAL CYSTECTOMY PREDICTS LYMPH NODE STATUS AND PATHOLOGICAL UPSTAGING

34. PD20-05 REAL-WORLD DATA: CALL FOR PARADIGM SHIFT TOWARDS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY—ANALYSIS OF THE ROBUUST REGISTRY

36. MP44-18 COMPARISON OF LATERAL FLANK APPROACH AND LOW ANTERIOR ACCESS FOR SINGLE PORT (SP) RETROPERITONEAL PARTIAL NEPHRECTOMY: AN ANALYSIS FROM THE SINGLE PORT ADVANCED RESEARCH CONSORTIUM (SPARC)

38. DEI-02 SURVIVAL OUTCOMES BY RACE ACROSS DIFFERENT CONTINENTS FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY

39. PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS

40. MP44-16 ADOPTION OF SINGLE PORT ROBOTIC PARTIAL NEPHRECTOMY INCREASES UTILIZATION OF THE RETROPERITONEAL APPROACH: A REPORT FROM THE SINGLE-PORT ADVANCED RESEARCH CONSORTIUM

42. MP44-17 COMPARISON OF OUTCOMES BETWEEN SINGLE-PORT AND MULTI-PORT ROBOTIC RADICAL NEPHRECTOMY: A REPORT OF THE SINGLE PORT ADVANCED RESEARCH CONSORTIUM (SPARC)

44. PD20-06 COMPARATIVE ANALYSIS OF NEOADJUVANT VERSUS ADJUVANT THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA IN THE SETTING OF CLINICAL NODE POSITIVE DISEASE: ANALYSIS OF THE ROBUUST REGISTRY

45. MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA

48. MP38-03 PREDICTORS AND OUTCOME OF LYMPH NODE INVOLVEMENT FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY FOR PRIMARY UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)

49. PD20-04 ROBOTIC DISTAL URETERECTOMY FOR HIGH-RISK DISTAL URETERAL UROTHELIAL CARCINOMA: A RETROSPECTIVE MULTICENTER COMPARATIVE ANALYSIS (ROBUUST COLLABORATIVE ANALYSIS)

50. MP38-17 REAL-WORLD MANAGEMENT OF HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: LEVEL OF ADHERENCE TO EAU-AUA GUIDELINES—ANALYSIS OF THE ROBUUST REGISTRY

Catalog

Books, media, physical & digital resources